Whitehawk Therapeutics Inc
Research Whitehawk Therapeutics Inc (WHWK) on Bullrun: market cap USD 218.09M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerWHWK
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 218.09M
- Financial periodFY2025
- RevenueUSD 7.15M
- Revenue growth-72.5%
- Net income-USD 20.60M
- Free cash flow-USD 97.99M
- Gross margin89.4%
Valuation Snapshot
latest market cap is USD 218.09M.
About Whitehawk Therapeutics Inc
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Frequently asked questions
What is Whitehawk Therapeutics Inc's market cap?
Whitehawk Therapeutics Inc's market capitalization is USD 218.09M.
What does Whitehawk Therapeutics Inc do?
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc.